Trailing-twelve-month (TTM) net income is ($3.40 Billion) A growth comparison is not meaningful when a comparison period reports a loss.. Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-27): $-5.46B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:45.641Z. Historical observations retain their original dates. Historical series through 2025-07-30.
($3.40B)
($3.40 Billion)
n/m
A growth comparison is not meaningful when a comparison period reports a loss.
N/A
Compound annual growth rate unavailable
1 Year
N/A
3 Year
N/A
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | ($5.85B) | ($8.59B) | (313.05%) |
| 2024 | $2.74B | ($111.00M) | (3.89%) |
| 2023 | $2.85B | +$492.00M | +20.82% |
| 2022 | $2.36B | +$1.35B | +133.50% |
| 2021 | $1.01B | +$656.00M | +184.27% |
| 2020 |
TTM Growth
n/m
3-Year CAGR
n/m
5-Year CAGR
n/m
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-12T00:15:45.641Z. Historical observations retain their original dates. Historical series through 2025-07-30.
| $356.00M |
| ($1.58B) |
| (81.60%) |
| 2019 | $1.94B | +$12.13B | N/A |
| 2018 | ($10.19B) | ($21.13B) | (193.15%) |
| 2017 | $10.94B | +$7.34B | +204.25% |
| 2016 | $3.60B | +$2.96B | +467.19% |
